Amentoflavone (20% extract) – Powder, 2.5 grams
Amentoflavone (20% extract) – Powder, 2.5 grams
Derzeit nicht verfügbar
NovaMeds
Pregnenolone is a pregnane-class steroid derived enzymatically from cholesterol via the cholesterol side-chain cleavage enzyme (CYP11A1), positioned as the common biosynthetic precursor for the entire downstream steroidogenic cascade.
Darreichungsform: Pregnenolone – Powder, 5 grams.
Mit KI erstellte illustrative Verpackung.
Nicht zur Anwendung bei Menschen oder Tieren.
Pregnenolone is a pregnane-class steroid derived enzymatically from cholesterol via the cholesterol side-chain cleavage enzyme (CYP11A1), positioned as the common biosynthetic precursor for the entire downstream steroidogenic cascade. Research interest centers on its role both as a steroidogenesis intermediate and as a neurosteroid with independent signalling activity in the central nervous system.
Research applications include steroidogenic pathway studies, neurosteroid receptor pharmacology, and CYP11A1 enzyme kinetics research.
| Chemical Formula | C21H32O2 |
|---|---|
| Synonyms | pregn-5-en-3β-ol-20-one, 3beta-Hydroxypregn-5-en-20-one, Arthenolone, Pregnetan |
| Molar Mass | 316.5 g/mol |
| CAS Number | 145-13-1 |
| PubChem CID | 8955 |
| Total Compound Content | 5 grams |
| Shelf Life | 36 months |
Pregnenolone is generated from cholesterol by CYP11A1 within mitochondria of steroidogenic tissue, representing the rate-limiting branch point from which all downstream steroid hormone classes — progestogens, glucocorticoids, mineralocorticoids, androgens, and estrogens — are ultimately derived through tissue-specific enzymatic pathways. Independently of its role as a biosynthetic intermediate, pregnenolone and its sulfate ester are studied as neurosteroids with reported direct modulatory activity at GABA-A and NMDA receptor complexes in neuronal tissue, a mechanism distinct from genomic steroid receptor signalling. Research models examine both the classical steroidogenic cascade (using steroidogenic cell lines such as adrenal or gonadal-derived cultures) and neurosteroid receptor-binding pharmacology in neuronal preparations. Independently third-party HPLC-tested; COA available per batch.
Pregnenolone is produced from cholesterol by the mitochondrial enzyme CYP11A1 (cholesterol side-chain cleavage enzyme), representing the first and rate-limiting committed step of steroidogenesis.
From pregnenolone, tissue-specific enzymatic pathways branch toward progesterone and downstream mineralocorticoids/glucocorticoids, or toward dehydroepiandrosterone (DHEA) and downstream androgens/estrogens, depending on which steroidogenic enzymes are expressed in a given tissue.
Research using pregnenolone as a substrate in steroidogenic cell models allows characterisation of which downstream enzymatic branch point is rate-limiting under specific experimental conditions.
Pregnenolone and its sulfated derivative (pregnenolone sulfate) are investigated for direct, rapid modulatory effects at neuronal ligand-gated ion channels — including GABA-A and NMDA receptor complexes — that occur independently of the genomic nuclear steroid receptor pathway used by downstream steroid hormones. Electrophysiological assays (patch-clamp recording of GABA-A or NMDA receptor currents) in the presence of pregnenolone or pregnenolone sulfate are the standard method for characterising this neurosteroid activity, distinct from steroidogenic enzyme-kinetics approaches used to study its biosynthetic role.
Steroidogenic cell lines (such as adrenocortical or Leydig cell-derived models) and isolated mitochondrial preparations expressing CYP11A1 are standard systems for studying cholesterol-to-pregnenolone conversion kinetics, typically using cholesterol substrate (often radiolabeled or isotope-labeled) and quantifying pregnenolone product formation by mass spectrometry or immunoassay over time. These models allow researchers to characterise how experimental conditions or co-treatments affect this rate-limiting steroidogenic step.